The COVID-19 vaccine may offer brain cancer patients a surprise benefit
A recent study adds to existing evidence that mRNA vaccines can prolong survival
Read the storyglioblastoma
2 STORIESReporting and perspectives on glioblastoma.
COVID-19 vaccine may offer brain cancer patients a surprise survival benefit
A preliminary, non-peer-reviewed study found that people with glioblastoma who received a COVID-19 vaccine within 100 days before biopsy or surgery lived twice as long as unvaccinated patients. The work shows an association, not cause and effect.
Read the story